Photocure (PHO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Photocure (PHO) has a cash flow conversion efficiency ratio of 0.103x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr62.78 Million ≈ $6.61 Million USD) by net assets (Nkr606.75 Million ≈ $63.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Photocure for the company's overall valuation and market capitalisation.
Photocure - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Photocure's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Photocure Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Photocure ranked by their cash flow conversion efficiency. Explore Photocure (PHO) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Huangshan Tourism Development Co Ltd B
SHG:900942
|
0.042x |
|
Expleo Solutions Limited
NSE:EXPLEOSOL
|
0.107x |
|
WCT Holdings Bhd
KLSE:9679
|
0.004x |
|
Castles Technology Co Ltd
TW:5258
|
0.095x |
|
Bank Jabar
JK:BJBR
|
-0.231x |
|
D O Green Technologies Bhd
KLSE:7204
|
0.022x |
|
GOLFZON Co. Ltd
KQ:215000
|
0.052x |
|
Bhageria Industries Limited
NSE:BHAGERIA
|
0.048x |
Annual Cash Flow Conversion Efficiency for Photocure (2002–2025)
The table below shows the annual cash flow conversion efficiency of Photocure from 2002 to 2025. View PHO stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Nkr484.23 Million ≈ $50.96 Million |
Nkr25.96 Million ≈ $2.73 Million |
0.054x | -64.96% |
| 2024-12-31 | Nkr501.72 Million ≈ $52.79 Million |
Nkr76.75 Million ≈ $8.08 Million |
0.153x | +151.36% |
| 2023-12-31 | Nkr482.85 Million ≈ $50.81 Million |
Nkr29.39 Million ≈ $3.09 Million |
0.061x | +1495.53% |
| 2022-12-31 | Nkr462.73 Million ≈ $48.69 Million |
Nkr-2.02 Million ≈ $-212.35K |
-0.004x | -109.18% |
| 2021-12-31 | Nkr502.63 Million ≈ $52.89 Million |
Nkr23.89 Million ≈ $2.51 Million |
0.048x | +54.94% |
| 2020-12-31 | Nkr508.13 Million ≈ $53.47 Million |
Nkr15.59 Million ≈ $1.64 Million |
0.031x | -69.03% |
| 2019-12-31 | Nkr208.59 Million ≈ $21.95 Million |
Nkr20.66 Million ≈ $2.17 Million |
0.099x | +172.38% |
| 2018-12-31 | Nkr176.34 Million ≈ $18.56 Million |
Nkr-24.12 Million ≈ $-2.54 Million |
-0.137x | -26.45% |
| 2017-12-31 | Nkr218.08 Million ≈ $22.95 Million |
Nkr-23.59 Million ≈ $-2.48 Million |
-0.108x | -242.01% |
| 2016-12-31 | Nkr251.94 Million ≈ $26.51 Million |
Nkr19.19 Million ≈ $2.02 Million |
0.076x | +176.09% |
| 2015-12-31 | Nkr210.06 Million ≈ $22.10 Million |
Nkr-21.03 Million ≈ $-2.21 Million |
-0.100x | -294.80% |
| 2014-12-31 | Nkr240.06 Million ≈ $25.26 Million |
Nkr-6.09 Million ≈ $-640.63K |
-0.025x | +93.16% |
| 2013-12-31 | Nkr269.12 Million ≈ $28.32 Million |
Nkr-99.72 Million ≈ $-10.49 Million |
-0.371x | -156.53% |
| 2012-12-31 | Nkr380.27 Million ≈ $40.02 Million |
Nkr-54.93 Million ≈ $-5.78 Million |
-0.144x | -84.12% |
| 2011-12-31 | Nkr439.34 Million ≈ $46.23 Million |
Nkr-34.47 Million ≈ $-3.63 Million |
-0.078x | -330.80% |
| 2010-12-31 | Nkr458.85 Million ≈ $48.28 Million |
Nkr15.60 Million ≈ $1.64 Million |
0.034x | -95.55% |
| 2009-12-31 | Nkr415.78 Million ≈ $43.75 Million |
Nkr317.44 Million ≈ $33.40 Million |
0.763x | +355.48% |
| 2008-12-31 | Nkr199.69 Million ≈ $21.01 Million |
Nkr-59.68 Million ≈ $-6.28 Million |
-0.299x | +18.77% |
| 2007-12-31 | Nkr259.99 Million ≈ $27.36 Million |
Nkr-95.66 Million ≈ $-10.07 Million |
-0.368x | -281.35% |
| 2006-12-31 | Nkr326.94 Million ≈ $34.40 Million |
Nkr66.33 Million ≈ $6.98 Million |
0.203x | +113.94% |
| 2005-12-31 | Nkr48.47 Million ≈ $5.10 Million |
Nkr-70.54 Million ≈ $-7.42 Million |
-1.455x | -147.85% |
| 2004-12-31 | Nkr85.57 Million ≈ $9.00 Million |
Nkr-50.25 Million ≈ $-5.29 Million |
-0.587x | -9.86% |
| 2003-12-31 | Nkr131.90 Million ≈ $13.88 Million |
Nkr-70.51 Million ≈ $-7.42 Million |
-0.535x | -75.36% |
| 2002-12-31 | Nkr167.00 Million ≈ $17.57 Million |
Nkr-50.91 Million ≈ $-5.36 Million |
-0.305x | -- |
About Photocure
Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through two segments, Commercial Franchise and Development Portfolio. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It is also developing Cevira, a photodynamic drug-device combination pro… Read more